Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-706,056
Closed -$96.2M 791
2025
Q2
$96.2M Buy
706,056
+112,983
+19% +$13.3M 0.28% 74
2025
Q1
$50.1M Buy
593,073
+114,396
+24% +$10M 0.16% 125
2024
Q4
$36.2M Buy
478,677
+388,107
+429% +$22.6M 0.11% 183
2024
Q3
$3.37M Sell
90,570
-25,732
-22% -$790K 0.01% 647
2024
Q2
$2.95M Buy
116,302
+94,903
+443% +$2.14M 0.01% 669
2024
Q1
$492K Buy
21,399
+97
+0.5% +$2.07K ﹤0.01% 940
2023
Q4
$366K Buy
21,302
+855
+4% +$15.2K ﹤0.01% 971
2023
Q3
$327K Buy
20,447
+273
+1% +$4.35K ﹤0.01% 974
2023
Q2
$309K Buy
20,174
+2,160
+12% +$24.5K ﹤0.01% 998
2023
Q1
$152K Buy
18,014
+3,633
+25% +$28.4K ﹤0.01% 1075
2022
Q4
$92.3K Buy
14,381
+833
+6% +$6.31K ﹤0.01% 1113
2022
Q3
$110K Buy
13,548
+702
+5% +$6.24K ﹤0.01% 1111
2022
Q2
$117K Buy
+12,846
New +$127K ﹤0.01% 1096

Other funds holding PLTR

Axa's PLTR Position: Q3 2025 in Review

Axa sold out of Palantir (PLTR) in Q3 2025, closing a stake of 706,056 shares — an estimated $96.2M sold.

Axa first reported a position in PLTR in Q2 2022 and held it in 13 quarters. The position peaked at $96.2M in Q2 2025. 2,831 funds tracked by Wall St. Rank hold PLTR as of Q3 2025.

  • Axa reported no remaining Palantir position as of Q3 2025 after selling out during the quarter.
  • Axa sold 706,056 Palantir shares in Q3 2025, an estimated $96.2M.
  • Axa first reported a position in Palantir in Q2 2022 and held it in 13 quarters.
  • Axa's Palantir position peaked at $96.2M in Q2 2025.
  • 2,831 funds tracked by Wall St. Rank held Palantir as of Q3 2025.

Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.